Glioblastoma, IDH-wildtype with primarily leptomeningeal localisation diagnosed by nanopore sequencing of cell-free DNA from cerebrospinal fluid
)
- Published on: September 3 2024
- Source: Acta Neuropathologica
Main menu
Getting started
Quick links
About Oxford Nanopore
© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.
ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.
ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.
Select options from the list below
English EnglishEspañol Español
中文 中文
日本語 日本語
0 result available.